[Psychomotor retardation and intermitent convulsions for 8 months in an infant]

Yuan Ding1, Xi-Yuan Li, Yu-Peng Liu

  • 1Department of Pediatrics, Peking University First Hospital, Beijing 100034, China. organic.acid@126.com.

Insights

Maternal phenylketonuria (PKU) caused a boy's psychomotor retardation and epilepsy. Family investigation is crucial for diagnosing developmental issues linked to parental conditions like PKU.

Area of Science:

  • Medical Genetics
  • Pediatric Neurology
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder.
  • Maternal PKU can lead to severe developmental issues in offspring.
  • Early diagnosis and management are critical for preventing complications.

Observation:

  • A 20-month-old boy presented with psychomotor retardation, epilepsy, and microcephaly.
  • Brain MRI revealed white matter demyelination and ventricular abnormalities.
  • Genetic analysis identified a homozygous mutation in the phenylalanine hydroxylase (PAH) gene in the mother, confirming PKU.

Findings:

  • The boy exhibited developmental quotient of 43 and epilepsy, consistent with fetal exposure to high phenylalanine levels.
  • The mother had undiagnosed PKU with markedly elevated blood phenylalanine levels.
  • The child was heterozygous for the PAH gene mutation, inheriting one copy from his mother.

Implications:

  • This case highlights the importance of family history and genetic screening in diagnosing developmental disorders.
  • Undiagnosed maternal PKU can cause significant, preventable brain damage in children.
  • Comprehensive clinical and metabolic evaluations of parents are essential for identifying disease-associated risks in offspring.

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
2.4K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.1K
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
328